This review argues that women’s higher Alzheimer disease risk may be shaped in part by midlife neuroendocrine aging, ...

D3 Bio Inc, a global clinical-stage biotechnology company focused on developing transformative oncology therapeutics, is pleased to announce that five abstracts have been accepted for presentation at ...

Recently published Epidermolysis Bullosa Market Insights report includes a comprehensive understanding of current treatment practices, epidermolysis bullosa emerging drugs, market share of individual ...

BOULDER, Colo., Feb. 26, 2026 /PRNewswire/ -- Transformative Biotech has appointed Mark Kelleher, PhD, as Executive Vice President of Research & Development, strengthening the leadership team as it ...

Pokémon turns 30 this year, and The Pokémon Company is celebrating that milestone in all number of ways, including creating a special 30th anniversary logo for every individual Pokémon. That's right, ...

The trial clearance for Shanghai-based Unixell is another step forward for the rapidly advancing Chinese biotech ecosystem, which has invested heavily in cell and gene therapy technology.

The growth of the epidermolysis bullosa market is expected to be mainly driven by increasing prevalence, patient awareness, label expansion of approved therapies, high cost of therapies, and ...

Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai" or the "Company"), today announced that it received a written ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received CE Mark approval for its Elecsys® Apolipoprotein E4 ...

Bharat Biotech celebrates 30 years of scientific innovation, unveiling a special anniversary logo. Founders Krishna and ...

Advanced proteomics and AI reveal blood protein changes, offering insights into early Alzheimer's detection and differentiation from mild cognitive impairment.